Navigation Links
Covance Elects John McCartney to Company's Board of Directors
Date:5/7/2009

PRINCETON, N.J., May 7 /PRNewswire-FirstCall/ -- Covance Inc. (NYSE: CVD) announced that it has elected John McCartney to its board of directors.

Mr. McCartney currently serves as chairman of the board of A.M. Castle Corporation, a provider of specialty products, services, and supply chain solutions. He was formerly president and chief operating officer of U.S. Robotics (USR), a multibillion dollar provider of information access technologies. He was a senior executive in the management team that grew USR from $7 million to $2 billion in revenue. Mr. McCartney also served on the board of USR for 12 years. He joined USR in 1984 as vice president and chief financial officer.

"We are very pleased to welcome Mr. McCartney to our board of directors. His accomplishments and more than 20 years of experience in general management, finance, and information technology services will strengthen Covance's strategy to provide high-quality drug development data to our clients worldwide and build a scalable management structure," said Joe Herring, Covance chairman and CEO.

"I am honored to be part of such an accomplished group of individuals," said Mr. McCartney. "I am looking forward to leveraging my experience to enhance Covance's ability to deliver integrated service solutions to its clients as well as drive value to its shareholders."

Mr. McCartney is currently a member of the board of directors of Huron Consulting Group, Incorporated, Federal Signal Corporation, and Datatec, Limited. He is also a member of the boards of Lycee Francais of Chicago, St. Ignatius College Prep, and the Graduate Advisory Board of the Wharton School of Business at the University of Pennsylvania.

Mr. McCartney graduated with a bachelor's degree in philosophy from Davidson College and earned his master's degree in business administration from the University of Pennsylvania's Wharton School of Business.

Covance, with headquarters in Princeton, New Jersey, is one of the world's largest and most comprehensive drug development services companies with annual revenues greater than $1.7 billion, global operations in more than 25 countries, and more than 9,800 employees worldwide. Information on Covance's products and services, recent press releases, and SEC filings can be obtained through its website at www.covance.com.


'/>"/>
SOURCE Covance Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Covance Reports First Quarter Revenue of $441M and EPS of $0.63; Updates Full Year Financial Targets
2. Covance Opens New Clinical Development Offices in Chile, Peru and Expands Argentina Office
3. Jina Ventures Advises Swiss Pharma Contract on Strategic Sale to Covance Inc
4. Covance Increases Early Clinical Footprint in Europe with Acquisition of Swiss-Based Early Clinical Development Site
5. Covance Purchases Equity Stake in Caprion Proteomics
6. Covance and Lilly Finalize 10-Year, $1.6 Billion Strategic R&D Collaboration
7. Covance Decides to Pursue Its Original Preclinical Strategy in China
8. Covance and WuXi PharmaTech to Form a Joint Venture to Provide World-Class Preclinical Services in China
9. Covance to Present at The R.W. Baird 2008 Growth Stock Conference
10. Covance to Present at Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference
11. Covance Reports Full-Year 2007 Revenue Growth Of 15.4% and Seventh Consecutive Year of EPS Growth in Excess of 20%
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... ... 27, 2016 , ... Newly created 4Sight Medical Solutions ... the healthcare market. The company's primary focus is on new product introductions, to ... that are necessary to help companies efficiently bring their products to market. , ...
(Date:6/24/2016)... TOKYO , June 24, 2016  Regular discussions on ... to take place between the two entities said Poloz. ... in Ottawa , he pointed to the ... and the federal government. ... Poloz said, "Both institutions have common economic goals, why not ...
(Date:6/23/2016)... ... June 23, 2016 , ... Mosio, a ... eBook, “Clinical Trials Patient Recruitment and Retention Tips.” Partnering with experienced clinical research ... by providing practical tips, tools, and strategies for clinical researchers. , “The landscape ...
(Date:6/23/2016)... A person commits a crime, and the detective ... the criminal down. An outbreak of foodborne illness ... (FDA) uses DNA evidence to track down the bacteria that ... It,s not. The FDA has increasingly used a complex, cutting-edge ... illnesses. Put as simply as possible, whole genome sequencing is ...
Breaking Biology Technology:
(Date:5/3/2016)... , May 3, 2016  Neurotechnology, a ... the MegaMatcher Automated Biometric Identification System (ABIS) ... large-scale multi-biometric projects. MegaMatcher ABIS can process multiple ... using any combination of fingerprint, face or iris ... MegaMatcher SDK and MegaMatcher Accelerator , ...
(Date:4/19/2016)... DUBAI , UAE, April 20, 2016 ... can be implemented as a compact web-based "all-in-one" system ... in the biometric fingerprint reader or the door interface ... requirements of modern access control systems. The minimal dimensions ... the ID readers into the building installations offer considerable ...
(Date:3/31/2016)... , March 31, 2016 ... ) ("LegacyXChange" or the "Company") LegacyXChange is ... users of its soon to be launched online site ... https://www.youtube.com/channel/UCyTLBzmZogV1y2D6bDkBX5g ) will also provide potential shareholders ... of DNA technology to an industry that is notorious ...
Breaking Biology News(10 mins):